CGTX
Cognition Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.05
-0.03 ▼ -2.78%
🌙 3월 13일 7:51 PM ET (한국 3/14 08:51)
$1.08
+0.03 ▲ +2.86%
| Index | - | P/E | - | EPS (ttm) | -0.47 | Insider Own | 10.74% | Shs Outstand | 0.09B | Perf Week | 1.94% |
| Market Cap | 0.09B | Forward P/E | - | EPS next Y | 14.1% | Insider Trans | - | Shs Float | 0.08B | Perf Month | -4.55% |
| Enterprise Value | 0.05B | PEG | - | EPS next Q | -0.08 | Inst Own | 17.58% | Short Float | 9.06% | Perf Quarter | -37.87% |
| Income | -0.03B | P/S | - | EPS this Y | 54.65% | Inst Trans | 0.19% | Short Ratio | 8.3 | Perf Half Y | -55.51% |
| Sales | 0.00B | P/B | 2.54 | EPS next 5Y | 20.63% | ROA | -78.86% | Short Interest | 7.14M | Perf YTD | -22.22% |
| Book/sh | 0.41 | P/C | 2.33 | EPS past 3/5Y | -5.37% -16.44% | ROE | -109.73% | 52W High | -72.58% ($3.83) | Perf Year | 153.01% |
| Cash/sh | 0.45 | P/FCF | - | Sales past 3/5Y | - | ROIC | -76.17% | 52W Low | 372.33% ($0.22) | Perf 3Y | -35.58% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 50.39% | Gross Margin | - | Volatility(W/M) | 7.08% 6.92% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.08 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 6.44 | EPS Q/Q | 74.3% | Profit Margin | - | RSI (14) | 43.76 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.44 | Sales Q/Q | - | SMA20 | -2.55% ($1.08) | Beta | 1.25 | Target Price | $3.5 |
| Payout | - | Debt/Eq | 0.01 | Earnings | 11000000 | SMA50 | -13.04% ($1.21) | Rel Volume | 0.47 | Prev Close | $1.08 |
| Employees | 28 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 33.33% - | SMA200 | -18.25% ($1.28) | Avg Volume(3M) | 0.86M | Price | $1.05 |
| IPO | 2021/10/8 | Option/Short | No/Yes | Trades | 1084 | Volume | 405,379 | Change | -2.78% |
뉴스 로딩 중...